Financial Performance Highlights - Revenue reached $2.2 billion, reflecting a 9% organic operational increase[12] - Adjusted Net Income was $662 million, a 6% organic operational increase[12] - Adjusted Diluted EPS was $1.48, an 8% organic operational increase[12] Segment Performance - U S segment revenue totaled $1.2 billion, with companion animal revenue at $1.0 billion showing 6% organic operational growth and 8% growth respectively[22] - International segment revenue reached $1.0 billion, with companion animal revenue at $0.6 billion and livestock revenue at $0.4 billion, demonstrating 11% and 12% organic operational growth respectively[23] Franchise Growth - Simparica franchise experienced 19% operational growth[13] - Key Dermatology franchise grew 10% operationally[13] - OA pain franchise increased 15% operationally[13] Updated Financial Guidance for 2025 - Revenue is projected between $9.425 billion and $9.575 billion[26] - Adjusted Net Income is expected to be between $2.775 billion and $2.825 billion[26] - Adjusted Diluted EPS is forecasted to be between $6.20 and $6.30[26]